
GC31689
Fiboflapon
Also listed as Fiboflapon (GSK2190915)
Fiboflapon (GSK2190915) (GSK2190915; AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein (FLAP) inhibitor with a potency of 2·9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood
ChemicalCAS936350-00-4MW637.83FormulaC38H43N3O4S
- CAS number
- 936350-00-4
- Molecular weight
- 637.83
- Formula
- C38H43N3O4S
- Solubility
- DMSO : 50 mg/mL (78·39 mM);Water : < 0·1 mg/mL (insoluble)
- InChIKey
- DFQGDHBGRSTTHX-UHFFFAOYSA-N
- Catalogue number
- GC31689
- Brand
- GLPBIO
Computed properties PubChem CID 44473151 · XLogP 7.8 · TPSA 112 Ų · H-bond donors 1
- XLogP
- 7.8
- TPSA
- 112 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Rotatable bonds
- 13
- Heavy atoms
- 46
SMILES CCOC1=NC=C(C=C1)C2=CC=C(C=C2)CN3C4=C(C=C(C=C4)OCC5=NC=C(C=C5)C)C(=C3CC(C)(C)C(=O)O)SC(C)(C)C
Computed descriptors from PubChem (CID 44473151), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il